Immunotherapy Outcomes in Advanced Melanoma in Relation to Age

INTRODUCTION: Older age is a melanoma risk factor. Elderly individuals are likelier to have immunosenescence, which could help melanoma cells escape immune surveillance. Hence, it is believed that elderly people cannot mount a potent immune response to checkpoint inhibitors to eliminate melanoma. OB...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Perm J
Main Authors: Joshi, Krishna, Atwal, Dinesh, Ravilla, Rahul, Pandey, Yadav, Yarlagadda, Naveen, Kakadia, Sunil, Makhoul, Issam, Hutchins, Laura, Mahmoud, Fade
Formato: Artigo
Idioma:Inglês
Publicado em: The Permanente Journal 2020
Assuntos:
Original Research & Contributions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039418/
https://ncbi.nlm.nih.gov/pubmed/32097116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/19.093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados